论文部分内容阅读
本文报道了在持续性室速(VT)或室颤(VF)的器质性心脏病患者中应用第三代植入式心脏复律-除颤器(TGICD)的经验。病例选择至少满足下列条件之一:(1)明确的心脏停搏或VF史;(2)持续30秒以上的、药物治疗无效或不能耐受药物的VT。尚需除外;(1)快速心室率的室上性心律失常;(2)由抗心律失常药物、代谢或电解质紊乱、急性心梗或急性心肌缺血引起的VT或 VF;(3)频繁的非持续性(VT)或连续反复的持续性VT;(4)预期生存期<6个月;(5)因医学或管理原因而不愿随访者。
This article reports on the experience of using a third generation implantable cardioverter-defibrillator (TGICD) in patients with structural heart disease with sustained ventricular tachycardia (VT) or ventricular fibrillation (VF). Case selection meets at least one of the following criteria: (1) a definite history of cardiac arrest or VF; (2) VT for drugs that are inactive or intolerant for more than 30 seconds. (1) supraventricular arrhythmias with rapid ventricular rate; (2) VT or VF induced by anti-arrhythmic drugs, metabolic or electrolyte disturbances, acute myocardial infarction, or acute myocardial ischemia; (3) frequent Non-persistent (VT) or continuous, continuous VT; (4) Expected survival <6 months; (5) Unwilling to follow up for medical or administrative reasons.